Interestingly, GLP-1RA-based drugs have been proven beneficial to some extent in dedicated trials and should be considered in patients with obesity and/or T2D and metabolic dysfunction-associated steatohepatitis (MASH) 90
It helps manage blood sugar levels, control appetite, and slow down digestion
NICE recommends PDE5 inhibitors (sildenafil, tadalafil) as first-line ED treatment, with success rates of 60-70% and well-characterised safety profiles
Quick Answer: Semaglutide does cause some muscle loss, with approximately 2540% of total weight lost coming from lean body mass, similar to other weight loss methods
Muscle Loss From Inadequate Nutrition and Exercise GLP-1 medications suppress appetite, which significantly reduces calorie intake
J Neurochemistry (2009) 108(1):15864